Condition: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4
rs117905900
in
CFB;CYP21A2
gene and
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4
PMID 19846853
2009 Atypical hemolytic-uremic syndrome.
PMID 19821824
2010 Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
PMID 20513133
2010 Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
PMID 17182750
2007 Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.
rs144812066
in
CYP21A2;CFB
gene and
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4
PMID 17182750
2007 Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.
PMID 20513133
2010 Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.